Literature DB >> 14873783

Limitations and indications in the treatment of cancer of the thyroid with radioactive iodine.

R W RAWSON, J E RALL, W PEACOCK.   

Abstract

Entities:  

Keywords:  IODINE, RADIOACTIVE/therapeutic use; THYROID GLAND/neoplasms

Mesh：

Substances：

Year:  1951        PMID： 14873783     DOI： 10.1210/jcem-11-10-1128

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  9 in total

1.  Do we read carefully?

Authors:  Mario Medvedec
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-09       Impact factor: 9.236

2.  CARCINOMA of the thyroid.

Authors: 
Journal:  Br Med J       Date:  1952-11-22

3.  Comparing pre-therapeutic 124I and 131I uptake tests with intra-therapeutic 131I uptake in benign thyroid disorders.

Authors:  Falk Gühne; Christian Kühnel; Martin Freesmeyer
Journal:  Endocrine       Date:  2017-03-07       Impact factor: 3.633

4.  TSH suppression in the management of thyroid nodules and thyroid cancer.

Authors:  O H Clark
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

5.  Pediatric endocrinology; notes on some recent advances.

Authors:  F L PLACHTE
Journal:  Calif Med       Date:  1953-11

6.  Decreased uptake after fractionated ablative doses of iodine-131.

Authors:  Hurng-Sheng Wu; Huey-Herng Hseu; Wan-Yu Lin; Shyh-Jen Wang; Yao-Chi Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-04       Impact factor: 9.236

7.  DNA double-strand breaks induced by decay of (123)I-labeled Hoechst 33342: role of DNA topology.

Authors:  Pichumani Balagurumoorthy; Ketai Wang; S James Adelstein; Amin I Kassis
Journal:  Int J Radiat Biol       Date:  2008-12       Impact factor: 2.694

8.  The Effect of Diagnostic Absorbed Doses from 131I on Human Thyrocytes in Vitro.

Authors:  Zbigniew Adamczewski; Mariusz Stasiołek; Bolesław Karwowski; Marek Dedecjus; Daria Orszulak-Michalak; Anna Merecz; Przemysław W Śliwka; Bartosz Puła; Andrzej Lewiński
Journal:  Int J Mol Sci       Date:  2015-06-29       Impact factor: 5.923

9.  A Clinical Trial of Optimal Time Interval Between Ablation and Diagnostic Activity When a Pretherapy RAI Scanning Is Performed on Patients With Differentiated Thyroid Carcinoma.

Authors:  Yafu Yin; Qiufen Mao; Song Chen; Na Li; Xuena Li; Yaming Li
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.